Literature DB >> 10397310

Identification of Clostridium botulinum with API 20 A, Rapid ID 32 A and RapID ANA II.

M K Lindström1, H M Jankola, S Hielm, E K Hyytiä, H J Korkeala.   

Abstract

Three commercially available test systems for the identification of anaerobic bacteria were evaluated for the identification of 18 proteolytic group I and 69 non-proteolytic group II Clostridium botulinum, four Clostridium sporogenes and 18 non-toxigenic group II C. botulinum-like strains. All proteolytic C. botulinum strains were misidentified by the Rapid ID 32 A and RapID ANA II, while 14 strains and all C. sporogenes strains were identified as C. botulinum or C. sporogenes by the API 20 A. Reversely, all non-proteolytic C. botulinum strains were misidentified by the API 20 A while the Rapid ID 32 A recognized 67 and RapID ANA II 68 strains. All C. sporogenes strains were recognized by the RapID ANA II, while the Rapid ID 32 A recognized one strain. All non-proteolytic non-toxigenic strains were identified as C. botulinum group II by the Rapid ID 32 A, 17 strains by the RapID ANA II, and one strain by the API 20 A. The results show that these test systems do not provide a reliable method for identification of C. botulinum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397310     DOI: 10.1111/j.1574-695X.1999.tb01293.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  Osteosynthesis-associated bone infection caused by a nonproteolytic, nontoxigenic Clostridium botulinum-like strain.

Authors:  Jean-Philippe Carlier; Guylène K'ouas; Alain Lozniewski; François Sirveaux; Philippe Cailloux; Francine Mory
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Identification of Clostridium species and DNA fingerprinting of Clostridium perfringens by amplified fragment length polymorphism analysis.

Authors:  Riikka Keto-Timonen; Annamari Heikinheimo; Erkki Eerola; Hannu Korkeala
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material.

Authors:  M Lindström; R Keto; A Markkula; M Nevas; S Hielm; H Korkeala
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

4.  Development of a combined selection and enrichment PCR procedure for Clostridium botulinum Types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs.

Authors:  M Dahlenborg; E Borch; P Rådström
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

Review 5.  Laboratory diagnostics of botulism.

Authors:  Miia Lindström; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 6.  Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.

Authors:  Michael W Peck; Theresa J Smith; Fabrizio Anniballi; John W Austin; Luca Bano; Marite Bradshaw; Paula Cuervo; Luisa W Cheng; Yagmur Derman; Brigitte G Dorner; Audrey Fisher; Karen K Hill; Suzanne R Kalb; Hannu Korkeala; Miia Lindström; Florigio Lista; Carolina Lúquez; Christelle Mazuet; Marco Pirazzini; Michel R Popoff; Ornella Rossetto; Andreas Rummel; Dorothea Sesardic; Bal Ram Singh; Sandra C Stringer
Journal:  Toxins (Basel)       Date:  2017-01-18       Impact factor: 4.546

7.  Prevalence of C. Botulinum and C. Perfringens Spores in Food Products Available on Polish Market.

Authors:  Tomasz Grenda; Magdalena Grabczak; Krzysztof Kwiatek; Andrzej Bober
Journal:  J Vet Res       Date:  2017-09-19       Impact factor: 1.744

8.  Clostridium Tetani Bacteremia From a Suspected Cutaneous Source.

Authors:  David Kazadi; Diana Zychowski; Caleb Skipper; Peter Teravskis; Glen T Hansen; Eloy E Ordaya
Journal:  Cureus       Date:  2022-03-04

9.  Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010.

Authors:  Piyada Wangroongsarb; Tomoko Kohda; Chutima Jittaprasartsin; Karun Suthivarakom; Thanitchi Kamthalang; Kaoru Umeda; Pathom Sawanpanyalert; Shunji Kozaki; Kazuyoshi Ikuta
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.